Connection

Carmen Suárez Fernández to Pyrimidines

Back to Details
This is a "connection" page, showing publications Carmen Suárez Fernández has written about Pyrimidines.
Carmen Suárez Fernández
Connection Strength
0.026
Pyrimidines
  1. Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma. Br J Cancer. 2018 09; 119(6):663-669.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.